View
2
Download
0
Category
Preview:
Citation preview
Situation Report No. #17
22 June 2020
https://www.who.int/bangladesh/emergencies/coronavirus-disease-(covid-19)-update/coronavirus-disease-(covid-2019)-bangladesh-situation-reports
Dead RecoveredConfirmedTested
In this issue of COVID-19
Morbidity and Mortality
Weekly Update (MMWU) #
17:
Detailed epidemiological update
on COVID-19 pandemic in
Bangladesh, week 15-22 June
2020, including:
dashboard with key figures;
daily and weekly
distribution of COVID-19
cases and related deaths;
growth factor of daily
COVID-19 cases
daily distribution of COVID-
19 cases and rolling three-
days average per division;
overall attack rate and per
division;
comparison data with
selected countries in South
East Asia;
death and recovery rates of
closed cases; and
number of COVID-19
laboratories and total
weekly number of samples
tested.
The banner says, Health Department of Bangladesh has declared Red Zone to contain spread of COVID-19 in a locality
Tested Confirmed Recovered Dead Hotline
630,719 115,786 46,719 1,502 12.6 million
Test/1 million New Cases Recovery Rate CFR% AR/1 million
3,703 3,480 40.3% 1.30% 679.8
Laboratories PPE Stock PoE Screening
62 COVID-19 Labs
Last days
110,699 Samples
1,254,742 347,536
2,746,999 23,525
63.7%
Inside Dhaka
Tests 184,391 7,029
18.4%
Positive Tests 474,847 347,233
2 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 22 June 2020/Vol.17
1. Highlights
As of 22 June 2020, according to the Institute of Epidemiology, Disease Control and Research (IEDCR), there are
115,786 confirmed COVID-19 cases1 in Bangladesh, including 1,502 related deaths; Case Fatality Rate (CFR) is
1.30%.
On 18 June 2020, the Civil Aviation Authority issued a circular notifying that with effect from 16 June until further
notice, all passenger flights to/from Bahrain, Bhutan, Hongkong, India, Kuwait, Malaysia, Maldives, Nepal, Oman,
KSA, Sri Lanka, Singapore, Thailand, Turkey, shall not be allowed to land at any Airport in Bangladesh. Full document:
www.caab.gov.bd
On 17 June 2020, the Ministry of Foreign Affairs (MoFA) issued a Note Verbal to inform that Diplomatic, Official and
Laissez Passer holders posted in diplomatic missions in Bangladesh and their family members (including holders of
ordinary passports) with valid visas will be exempted from the requirement to submit COVID-19 negative/COVID-
19 symptom free medical certificate upon arrival. The diplomatic missions are requested to ensure self-quarantine
of their diplomats/employees upon travelling to Bangladesh. Full document: https://mofa.gov.bd
2. Coordination
On 21 June 2020, the Ministry of Public Administration issued a notification that in accordance with the 2018 Infectious
Diseases (Prevention, Control and Eradication) Act certain areas in ten (10) districts in the country were declared as ‘Red
Zones’. The Ministry of Public Administration further declared conditional general holidays in the Red Zones for the
period of 21 days, these general holidays will be applicable to all the officials/employees of government, semi-
government, autonomous, private offices/organizations of the specified Red Zone areas, and who live outside the areas.
The emergency services will be excluded from these general holidays. Full document: www.mopa.gov.bd
The technical working group on PPE quality control (TWG on PPE QC) developed a draft guideline for PPE visual
inspection, for consideration by DGDA. The document aims to guide local producers and importers of PPE on the
sampling methods and algorithms for ensuring compliance of PPE batches with the specifications and explains methods
to conduct visual inspection for the most common PPE items. It is also a useful guide to procurement agencies and
buyers to conduct a quality check of PPE upon delivery. The guide was drafted by Japanese inspection firm K2 with
financial support from JICA, with technical inputs from the other technical working group members. The technical
working group is coordinated by WHO and includes members from BUET, icddr,b, USAID, JICA and K2. The guide will be
considered by DGDA. After review, it is expected that the guide will be posted for public comments on the DGDA website
and then finalized after incorporation of stakeholders’ feedback. The TWG also produced draft parameters for testing
cloth masks, for consideration by DGDA.
MoHFW established a technical committee on Investigational New Drugs (IND). Membership of the committee
comprises of 12 participants coordinated by DGDA and chaired by Bangabandhu Shaikh Mujibur Rahman Medical
University (BSMMU). Members include senior academicians and clinicians. The committee aims to advise DGDA on the
evaluation of locally produced or imported medicines, investigational drugs, vaccines and medical devices to treat,
prevent or detect Covid-19, as a public health emergency. On Sunday 21 June, DGDA convened a technical committee
meeting for consultation on the minimum sensitivity and specificity level of serological test for COVID-19. The committee
will be meeting regularly to ensure expedited decisions on access to new products related to COVID-19 management.
1 WHO Bangladesh COVID-19 Situation Reports present official counts of confirmed COVID-19 as announced by the IEDCR and DGHS
on the indicated date. Difference in data between the WHO reports and other sources can result from using different cutoff ti mes for
the aggregation and reporting of the total number of new cases in the country .
3 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 22 June 2020/Vol.17
3. Surveillance and Laboratory
Between 9 March and 22 June 2020, according to the Institute of Epidemiology, Disease Control and Research (IEDCR)
there were fifteen-thousand-seven-hundred-eighty-six (115,876) COVID-19 confirmed by rt-PCR, including one-
thousand five-hundred-two (1,502) related death cases (CFR 1.30%).
In the current week (epidemiological week 25), COVID-19 confirmed cases increased by 14%, in comparison to the
previous week (24,786 and 21,751 respectively). In comparison to the previous epidemiological week, while the number
of COVID-19 related deaths increased by 3.2% (292 and 283 respectively), the overall Case Fatality Rate (CFR) decreased
from 1.34% in epidemiological week 24 to 1.30% in the current week.
The figures below are showing the daily and weekly distribution of reported confirmed COVID-19 cases and
deaths, 09 March – 22 June 2020, Bangladesh.
0
50
100
150
200
250
300
350
0
5,000
10,000
15,000
20,000
25,000
30,000
w10 w11 w12 w13 w14 w15 w16 w17 w18 w19 w20 w21 w22 w23 w24 w25
Weekl
y D
eath
s
Weekl
y C
ase
s
# Cases # Deaths
60
45
30
15
0
15
30
45
60
75
90
-4,000
-3,000
-2,000
-1,000
0
1,000
2,000
3,000
4,000
09/03 16/03 23/03 30/03 06/04 13/04 20/04 27/04 04/05 11/05 18/05 25/05 01/06 08/06 15/06 22/06
Num
ber
of D
eath
s (n
=1,5
01)
Num
ber
of C
ase
s (N
=115,7
86)
# Cases # Deaths
Poly. ( # Cases ) Poly. (# Deaths)
4 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 22 June 2020/Vol.17
In the current week (epidemiological week 25), COVID-19 Attack Rate (AR) increased by 28.3%, in comparison to the
previous week (659 and 514 respectively).
The figure below is showing the weekly attack rate confirmed COVID-19 cases, 08 March – 22 June 2020,
Bangladesh.
Growth factor (every day's new cases / new cases on the previous day) between 0 and 1 indicates a decline; when it is
above 1 it signals an increase, and if is persistently above 1 this could signify exponential growth. On April 3, the Growth
factor (GF) for COVID-19 cases in Bangladesh reached the highest of 2.5, the GF was above 2 on 9 and 12 April. Since
the beginning of June 2020, the GF was within the range of 0.8 – 1.2, and on 22 June 2020, the GF is 1.0.
The figure below is showing the Growth Factor of daily confirmed COVID-19 cases, 08 March – 22 June 2020,
Bangladesh.
0.0
0.5
1.0
1.5
2.0
2.5
3.0
08/0
3
11/0
3
14/0
3
17/0
3
20/0
3
23/0
3
26/0
3
29/0
3
01/0
4
04/0
4
07/0
4
10/0
4
13/0
4
16/0
4
19/0
4
22/0
4
25/0
4
28/0
4
01/0
5
04/0
5
07/0
5
10/0
5
13/0
5
16/0
5
19/0
5
22/0
5
25/0
5
28/0
5
31/0
5
03/0
6
06/0
6
09/0
6
12/0
6
15/0
6
18/0
6
21/0
6
Gro
wth
Fact
or
Growth Factor 2
Growth Factor 1
0.0
1
0.0
2
0.1
0.3
1 4 14 32 5
6 86
131
197
277
386
514
659
0.00
100.00
200.00
300.00
400.00
500.00
600.00
700.00
800.00
w10 w11 w12 w13 w14 w15 w16 w17 w18 w19 w20 w21 w22 w23 w24 w25
Weekl
y A
ttack
Rate
per
Millio
n
5 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 22 June 2020/Vol.17
As of 22 June 2020, the case doubling time in Bangladesh remains eight (8.0) days (about 1/2 day) more than the
previous update on 15 June 2020). Available data allows us to see how quickly the number of confirmed cases increased
in Bangladesh and some other countries in the WHO South-East Asia region: India, Indonesia, Thailand and Sri Lanka.
The figure below is showing the growth of COVID-19 confirmed cases in selected South East Asian countries
starting from the day they reported 100 confirmed cases, 22 June 2020.
As of 22 June 2020, the death doubling time in Bangladesh remains teen (10.0) days (no change from the previous
update on 15 June 2020). Available data allows us to see how quickly the number of confirmed deaths increased in
Bangladesh and some other countries in the WHO South-East Asia region: India, Indonesia, Thailand and Sri Lanka
The figure below is showing the growth of COVID-19 confirmed deaths in selected South East Asian countries
starting from the day they reported 100 confirmed cases, 22 June 2020.
100
1000
10000
100000
0 10 20 30 40 50 60 70 80 90
Num
ber
of C
ase
s
Days since 100th Confirm Case
India Indonesia
Malaysia Sri Lanka
Thailand Bangladesh
D1 D2 D3 D4 D5 D6 D7
D40
D20
D15
D12
D10
D8
D9
5
50
500
5000
0 10 20 30 40 50 60 70 80 90
Num
ber
of D
eath
s
Days since 5th Confirm Death
India Indonesia
Malaysia Sri Lanka
Thailand Bangladesh
D1 D2 D3 D5D4 D6 D7
D8
D9
D10
D12
D15
D20
D40
6 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 22 June 2020/Vol.17
As of 22 June 2020, geographical distribution of confirmed reported COVID-19 cases was available on 97% of cases
(112,306/115,786); of which 13.4% from Chattogram division, 3.2% from Rajshahi division, 2.6% from Sylhet division,
2.1% from Mymensingh division, 2.1% from Khulna division, 2.0% from Rangpur division, and 1.8% from Barisal
division.
The figure below is showing the daily distribution of reported confirmed COVID-19 cases per division (except
Dhaka city), 16 April – 21 June 2020, Bangladesh.
The case doubling time can be used to determine how fast COVID-19 infection has been spreading in the country.
Available data allows us to see how quickly the number of confirmed cases increased in different divisions in Bangladesh.
As of 22 June 2020, the case doubling time is 6 days in Dhaka division and Chattogram; in Khulna, Sylhet and Rajshahi
divisions - 7 days, in Rangpur, Mymensingh and Barisal divisions - 9 days.
The figure below is showing the case-doubling time of COVID-19 confirmed cases in all divisions starting from
the day each reported 10 confirmed cases, 22 June 2020, Bangladesh.
10
100
1,000
10,000
0 10 20 30 40 50 60 70
Num
ber
of C
ase
s
Days since 10th Confirm Case
BSL CTG DHK KLN
MYM RSH RNP SYT
D1 D2 D3 D5
D8
D15
D4 D6
D7
D10
D12
D20
D40
0
200
400
600
800
1,000
1,200
1,400
16/0
4
19/0
4
22/0
4
25/0
4
28/0
4
01/0
5
04/0
5
07/0
5
10/0
5
13/0
5
16/0
5
19/0
5
22/0
5
25/0
5
28/0
5
31/0
5
03/0
6
06/0
6
09/0
6
12/0
6
15/0
6
18/0
6
21/0
6
Num
ber
of C
ase
s
Chattogram Mymensingh Ranjpur Sylhet Rajshahi Khulna Barishal
7 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 22 June 2020/Vol.17
The case doubling time is 6 days in Dhaka city, Faridpur district – 7 Days, Narayanganj and Gazipur districts - 8 days,
Munshiganj district – 9 days, and slightly more than 10 days for Kishoreganj district.
The figure below is showing the growth of COVID-19 confirmed cases in all districts of Dhaka division starting
from the day each reported 10 confirmed cases, 22 June 2020, Bangladesh.
In Chattogram division till 22 June 2020, the case doubling time was the fastest in Noakhali district - 6 days,
Chattogram, Cox’s Bazar and Feni districts - 7 days, Cumilla district - 8 days, Chandpur district - 10 days and 15 days
for Laxmipur and Chandpur districts.
The figure below is showing the growth of COVID-19 confirmed cases in all districts of Chattogram division
starting from the day each reported 10 confirmed cases, 22 June 2020, Bangladesh.
10
100
1,000
10,000
0 10 20 30 40 50 60 70
Num
ber
of C
ase
s
Days since 10th Confirm Case
DHK_district DHK_city Faridpur
Gazipur Kishoreganj Munshiganj
Narayanganj
D1 D2 D3 D5
D8
D15
D4
D6
D7
D10
D12
D20
D40
10
100
1,000
10,000
0 10 20 30 40 50 60 70
Num
ber
of C
ase
s
Days since 10th Confirm Case
Chandpur Chattogram Cox's Bazar
Cumilla Feni Lakshmipur
Noakhali
D1 D2 D3 D5
D8
D15
D4D6
D7
D10
D12
D20
D40
8 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 22 June 2020/Vol.17
0
50
100
150
200
250
16/0
4
19/0
4
22/0
4
25/0
4
28/0
4
01/0
5
04/0
5
07/0
5
10/0
5
13/0
5
16/0
5
19/0
5
22/0
5
25/0
5
28/0
5
31/0
5
03/0
6
06/0
6
09/0
6
12/0
6
15/0
6
18/0
6
21/0
6
Sylhet 3 per. Mov. Avg. (Sylhet)
0
500
1,000
1,500
2,000
2,500
3,000
16/0
4
19/0
4
22/0
4
25/0
4
28/0
4
01/0
5
04/0
5
07/0
5
10/0
5
13/0
5
16/0
5
19/0
5
22/0
5
25/0
5
28/0
5
31/0
5
03/0
6
06/0
6
09/0
6
12/0
6
15/0
6
18/0
6
21/0
6
Dhaka 3 per. Mov. Avg. (Dhaka)
0
50
100
150
200
250
300
16/0
4
19/0
4
22/0
4
25/0
4
28/0
4
01/0
5
04/0
5
07/0
5
10/0
5
13/0
5
16/0
5
19/0
5
22/0
5
25/0
5
28/0
5
31/0
5
03/0
6
06/0
6
09/0
6
12/0
6
15/0
6
18/0
6
21/0
6
Rajshahi 3 per. Mov. Avg. (Rajshahi)
0
150
300
450
600
750
900
16/0
4
19/0
4
22/0
4
25/0
4
28/0
4
01/0
5
04/0
5
07/0
5
10/0
5
13/0
5
16/0
5
19/0
5
22/0
5
25/0
5
28/0
5
31/0
5
03/0
6
06/0
6
09/0
6
12/0
6
15/0
6
18/0
6
21/0
6
Chattogram 3 per. Mov. Avg. (Chattogram)
The figures below are showing the daily distribution of reported confirmed COVID-19 cases and rolling three-
days average per division, 16 April – 21 June 2020, Bangladesh.
9 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 22 June 2020/Vol.17
0
30
60
90
120
150
180
16/0
4
19/0
4
22/0
4
25/0
4
28/0
4
01/0
5
04/0
5
07/0
5
10/0
5
13/0
5
16/0
5
19/0
5
22/0
5
25/0
5
28/0
5
31/0
5
03/0
6
06/0
6
09/0
6
12/0
6
15/0
6
18/0
6
21/0
6
Barishal 3 per. Mov. Avg. (Barishal)
0
50
100
150
200
250
16/
04
19/
04
22/
04
25/
04
28/
04
01/
05
04/
05
07/
05
10/
05
13/
05
16/
05
19/
05
22/
05
25/
05
28/
05
31/
05
03/
06
06/
06
09/
06
12/
06
15/
06
18/
06
21/
06
Khulna 3 per. Mov. Avg. (Khulna)
0
50
100
150
200
250
16/0
4
19/0
4
22/0
4
25/0
4
28/0
4
01/0
5
04/0
5
07/0
5
10/0
5
13/0
5
16/0
5
19/0
5
22/0
5
25/0
5
28/0
5
31/0
5
03/0
6
06/0
6
09/0
6
12/0
6
15/0
6
18/0
6
21/0
6
Rangpur 3 per. Mov. Avg. (Rangpur)
0
30
60
90
120
15016/0
4
19/0
4
22/0
4
25/0
4
28/0
4
01/0
5
04/0
5
07/0
5
10/0
5
13/0
5
16/0
5
19/0
5
22/0
5
25/0
5
28/0
5
31/0
5
03/0
6
06/0
6
09/0
6
12/0
6
15/0
6
18/0
6
21/0
6
Mymensingh 3 per. Mov. Avg. (Mymensingh)
10 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 22 June 2020/Vol.17
The overall COVID-19 attack rate (the total number of cases divided by the total population) in Bangladesh [1]
has been
on a steady increase since 4 April 2020. On 22 June, Bangladesh attack rate (AR) is 679.9 per 1 million, and 100%
(64/64) of districts with the total population of 170,306,468 people have confirmed COVID-19 cases.
According to the available data for 112,306 cases, the highest AR continues to be observed in the Dhaka division
(1,893.3/1,000,000). Within the Dhaka division, Dhaka city has the highest AR (7,612.2/1,000,000), followed by
Narayanganj district (1,332.0/1,000,000), Munshiganj (1,039.1/1,000,000), Gazipur (1,039.1/1,000,000), Faridpur
(548.7/1,000000), Dhaka district (466.4/1,000,000), Narshingdi (461.9/1,000,000), Madaripur (397.5/1,000,000),
Kishoreganj (354.4/1000,000), Gopalganj (331.8/1,000,000), Manikganj (286.6/1,000,000), Shariatpur
(276.6/1,000,000), Rajbari (166.0/1,000,000), and the lowest AR 99.7/1,000,000 was reported from Tangail district.
The second highest COVID-19 Attack Rate is reported from Chattogram division of (274.8/1,000,000) having all of the
11 districts AR over 100 per million. Within the division, Cox’s Bazar district reported the highest AR (735.4/1,000,000)
followed by Chattogram (698.6/1,000,000), Noakhali (458.0/1,000,000), Cumilla (408.5/1,000,000), Bandarban
(394.2/1000,000), Feni (384.2/1,000,000), Lakshmipur (281.2/1,000,000), Rangamati (220.0/1,000,000), Chandpur
(193.9/1,000,000), Khagrachhari (172.2/1,000,000), and the lowest reported from Brahmanbaria (158.7/1,000,000)
district.
The third highest AR in the country was reported from Sylhet division (246.2/1000,000) with the highest AR in Sylhet
district (387.4/1000,000) followed by Sunamganj (262.2/1,000,000), Habiganj (129.6/1,000,000) and Maulvibazar
(100.0/1,000,000) district.
Barishal division is the fourth highest in overall AR with 205.3/1,000,000 with the highest AR in Barishal district
(427.6/1,000,000) followed by Jhalakathi (153.6/1,000,000), Barguna (153.5/1,000,000), Patuakhali (131.6/1,000,000),
Pirojpur (101.8/1,000,000) and Bhola (89.0/1,000,000) district.
Mymensingh division reported overall AR (180.6/1,000,000). Within the Mymensingh division, Mymensingh district
has the highest AR (217.6/1,000,000) followed by Jamalpur (168.2/1,000,000), Netrokona (144.5/1,000,000) and
Sherpur (121.4/1,000,000) district.
Rajshahi division has overall AR (164.0/1,000,000) with the highest AR in Bogura (522.8/1,000,000), followed by
Joypurhat (235.1/1,000,000).
The following figure is showing the attack rate per 1,000,000 population of reported confirmed COVID-19 cases
in selected divisions, 13 April - 21 June 2020, Bangladesh.
0
100
200
300
400
500
16/0
4
19/0
4
22/0
4
25/0
4
28/0
4
01/0
5
04/0
5
07/0
5
10/0
5
13/0
5
16/0
5
19/0
5
22/0
5
25/0
5
28/0
5
31/0
5
03/0
6
06/0
6
09/0
6
12/0
6
15/0
6
18/0
6
21/0
6
Att
ack R
ate
/1,0
00,0
00
CTG RNP KLN MYM BSL SYT
11 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 22 June 2020/Vol.17
Out of the total 115,786 conformed COVID-19 registered as of 22 June 2020, 40.3% (46,719/115,786) of the cases
recovered, 58.4% are active cases and 1.3% - died.
The figure below is showing the outcomes of reported confirmed COVID-19 cases outcome per epidemiological
week, 08 March – 22 June 2020, Bangladesh.
As of 22 June 2020, there were 48,220 (48.2%) COVID-19 cases with known outcome (closed cases), and out of all closed
cases 96.9% (46,719/48,220) were cured and 3.1% (1,502) died. The death rate on closed cases in Bangladesh is lower
than the 8.8% (471,199/5,326,333) global average as of 22 June 2020.
The figure below is showing the death and recovery rates over cumulative closed confirmed COVID-19 cases, 11
March – 22 June 2020, Bangladesh.
2
3
4
25
57
54
32
51
100 152
170 238
283
292
1
10
100
1000
10000
100000
w10 w11 w12 w13 w14 w15 w16 w17 w18 w19 w20 w21 w22 w23 w24 w25
Weekly Recovery Weekly Active
# Deaths Log. (Weekly Recovery)
0%
20%
40%
60%
80%
100%
11/0
3
14/0
3
17/0
3
20/0
3
23/0
3
26/0
3
29/0
3
01/0
4
04/0
4
07/0
4
10/0
4
13/0
4
16/0
4
19/0
4
22/0
4
25/0
4
28/0
4
01/0
5
04/0
5
07/0
5
10/0
5
13/0
5
16/0
5
19/0
5
22/0
5
25/0
5
28/0
5
31/0
5
03/0
6
06/0
6
09/0
6
12/0
6
15/0
6
18/0
6
21/0
6
Num
ber
of C
lose
d C
ase
s (N
=48220)
Death% Recovery%
12 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 22 June 2020/Vol.17
As of 22 June 2020, according to IEDCR, a total of 630,719 COVID-19 tests with the overall positivity rate of 18.4% were
conducted in Bangladesh by 62 laboratories (32 laboratories in Dhaka city and 30 laboratories in outside Dhaka). The
latest laboratories, which have started the testing: in Dhaka - Zainul Haque Sikder Women's Medical College and Hospital
Ltd., and AMZ Hospital Ltd. 63.9% of all samples were tested by laboratories in the Dhaka city, and 36.1% - outside
Dhaka. Notably, the number of samples does not represent the number of individuals tested, as some patients may be
tested more than once/several times.
The graph below is showing the weekly and cumulative number of COVID-19 conducted tests, 08 March – 22 June
2020, Bangladesh.
COVID-19 testing coverage has been gradually increasing in Bangladesh, reaching now 3,703/1,000,000 but is still lower
than in Maldives (65,771/1,000,000), Malaysia (21,140/1,000,000), Nepal (15,435/1,000,000), Thailand
(6,708/1,000,000), Sri Lanka (4,441/1,000,000) and India (5,038/1,000,000).
The graph below is showing the daily cumulative number of COVID-19 tests per 1,000,000 population, 08 March
– 22 June 2020, Bangladesh.
0 T
100 T
200 T
300 T
400 T
500 T
600 T
10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Epi Week
Tests N =
Positive N =
08 March 2020
First Bangladesh case reported
630.7 Thousand
As of 22 June 2020
115,786
630,719
234 368 786 1,774 6,577 14,17222,764
34,845
41,123
110,699
52,821
68,175
65,347
89,057
106,478
0
1000
2000
3000
4000
0
5000
10000
15000
20000
08-0
3
11-0
3
14-0
3
17-0
3
20-0
3
23-0
3
26-0
3
29-0
3
01-0
4
04-0
4
07-0
4
10-0
4
13-0
4
16-0
4
19-0
4
22-0
4
25-0
4
28-0
4
01-0
5
04-0
5
07-0
5
10-0
5
13-0
5
16-0
5
19-0
5
22-0
5
25-0
5
28-0
5
31-0
5
03-0
6
06-0
6
09-0
6
12-0
6
15-0
6
18-0
6
21-0
6
Num
ber
of Test
s (N
=630,7
19)
# Test Tests/1,000,000 Population
13 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 22 June 2020/Vol.17
4. Contact Tracing, Points of Entry (PoEs) and Quarantine
According to the DGHS, as of 15 June 2020, the current institutional quarantine capacity in the country is represented
by 629 centres across 64 districts, which can receive 31,991 persons. A total of 17,837 individuals were placed in
quarantine facilities and of them 13,708 (76.9%) have been already released. By 22 June 2020, in total 20,432 individuals
were isolated in designated health facilitates all over the country, of them 7,965 (37%) have been released, and 12,467
(61%) are presently in isolation facilities.
The highest number of people (6,547) in quarantine facilities was reported on 24 April 2020 while presently, the figure
reduced to 4,129. Between 17 March to 22 June 2020, total 324,409 individuals were placed under home quarantine all
the over the county and to date 81.6% (364,642/324,409) have been already released. Remaining 18.4% (59,765
individuals) are in home quarantine now.
The figures below are showing the number of individuals in home and facility quarantine and individuals in
isolation, 17 Mach – 22 June 2020, Bangladesh.
1,6
36
1,6
94
1,7
94
1,7
71
1,8
74
2,0
17
2,1
15
2,2
36
2,3
61
2,4
35
2,5
70
2,7
48
3,0
46
3,2
48
3,3
83
3,6
16
3,8
16
3,8
97
4,0
60
4,3
05
4,4
64
4,6
53
4,7
70
4,9
94
4,9
84
5,1
40
5,5
29
5,7
94
6,0
21
6,2
40
6,4
98
6,7
54
6,9
46
7,1
62
7,3
99
7,5
52
7,8
93
8,2
43
8,7
61
9,0
12
9,3
40
9,7
58
10,0
26
10,3
02
10,7
52
11,0
26
11,4
74
11,9
15
12,1
90
12,4
67
0
5,000
10,000
15,000
20,000
25,000
04/0
5
07/0
5
10/0
5
13/0
5
16/0
5
19/0
5
22/0
5
25/0
5
28/0
5
31/0
5
03/0
6
06/0
6
09/0
6
12/0
6
15/0
6
18/0
6
21/0
6
Presently in Isolation Hospital Isolation Released from Isolation
70
92
113
137
138
162
130
84
66
64
98
233
781
1,4
03
2,1
21
3,2
63
4,0
73
4,6
44 6,1
12
6,5
47
6,4
16
6,4
81
5,7
72
5,3
90
5,3
01
5,1
05
4,9
26
4,2
57
4,1
84
4,0
06
4,0
82
4,0
03
4,0
58
3,6
80
3,4
88
3,5
98
3,6
77
3,6
66
3,6
71
3,5
74
3,6
84
3,6
25
3,4
58
3,4
50
3,5
48
3,7
63
3,8
48
3,8
87
3,9
79
0
4,000
8,000
12,000
16,000
20,000
17/0
3
20/0
3
23/0
3
26/0
3
29/0
3
01/0
4
04/0
4
07/0
4
10/0
4
13/0
4
16/0
4
19/0
4
22/0
4
25/0
4
28/0
4
01/0
5
04/0
5
07/0
5
10/0
5
13/0
5
16/0
5
19/0
5
22/0
5
25/0
5
28/0
5
31/0
5
03/0
6
06/0
6
09/0
6
12/0
6
15/0
6
18/0
6
21/0
6
Presently in Facility Quarantine Total Facility Quarantined
14 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 22 June 2020/Vol.17
5. Case Management and infection Control
An updated version of the Emergency Global Supply Chain System (COVID -19) Catalogue was released. The catalogue
lists all medical devices, including personal protective equipment, medical equipment, medical consumables, single use
devices, laboratory and test-related devices that may be requested through the COVID-19 Supply Portal. In Bangladesh,
a group of development partners (DPs) and government officials are coordinating procurements related to COVID-19,
in support of the national response. The Pillar is chaired by WFP with participation of relevant partners under the DGHS
leadership. A system has been established to validate procurement requests from partners to ensure alignment with the
overall national needs, for COVID-19 response. Full document: https://www.who.int/publications/i/item/emergency-
global-supply-chain-system-(covid-19)-catalogue.
Two (2) meetings of the WHO global technical advisory group (TAG) on PPE specifications and testing parameters were
conducted during the past week. The group includes members from CDC/NIOSH, EU notifying body laboratories,
International Medical Corps, CHAI, UNICEF, Saudi FDA (WHO collaborating centre for medical devices), WHO and others.
The TAG discussed technical specifications and testing parameters for surgical gowns and surgical and examination
gloves. The decisions of the group are subject to online voting by the experts and will inform WHO’s updated technical
requirements for PPE in the disease commodity package for COVID-19. WHO list of priority medical devices for COVID-
19 prevention, diagnostic and management is available at the following link:
https://www.who.int/medical_devices/priority/COVID-19/en/.
On 16 June 2020, WHO Regional Office for South-East Asia (SEARO) hosted a virtual meeting on Antimicrobial
stewardship during the COVID-19 pandemic: best practice and guidance on prescribing antibiotics. The webinar
provided a brief about key principles & good practices for antimicrobial stewardship during the COVID-19 pandemic
and discussed recent updates from WHO on managing COVID-19 patients. The webinar targeted physicians and other
health care professionals involved in care of COVID-19 patients, policy makers, experts in charge of national antibiotic
policies and clinical guidelines, and WHO and development partner staff. The WHO toolkit on antimicrobial stewardship
programmes in health-care facilities in low- and middle-income countries is available at the following link
https://apps.who.int/iris/rest/bitstreams/1257395/retrieve. An online course on Antimicrobial Stewardship: A
competency-based approach is available at the following link https://openwho.org/courses/AMR-competency.
On 20 June 2020, a consultative meeting was held on Bangladesh’s participation in the WHO Solidarity trials for
candidate medicines for COVID-19 treatment. The IEDCR has been assigned by MoH&FW as a focal point for the trial
and is coordinating efforts of research institutions and health facilities to develop local protocols, based on the WHO
global protocols, and other aspects of the study. It was decided that Chloroquine/Hydroxychloroquine will be excluded
from the study. Sample size, ethical approval and randomization were discussed during the meeting.
6. Risk Communication and Public Awareness
RCCE partners are scaling up communication and information activities towards the use of masks as one of the main
components of protection measures against COVID-19 for the general public, together with maintaining physical
distancing and sustaining hygiene practices. Infographics and audio-video materials have been developed by the DGHS
with support from RCCE partners and are currently being disseminated through RCCE network. Additional materials-
public service announcements (PSA), instructional videos and mass media materials are being produced for wide
dissemination.
Furthermore, intensified RCCE activities have been conducted focusing on domestic violence and child protection as
well as on stigma and discrimination in order to address the increasing incidence of the issues in communities, especially
attitudes towards frontline responders, including health workers.
Ongoing activities are implemented to address disinformation, misinformation and rumors especially in online
environment, with constant efforts to eliminate or reduce the spread of such information in social media, promoting
accurate and reliable information.
15 | P a g e
WHO Bangladesh COVID-19 Morbidity and Mortality Weekly Update (MMWU) 22 June 2020/Vol.17
Contact: Dr Bardan Jung Rana, WHO Representative to Bangladesh, ranab@who.int
Dr Hammam El Sakka, Senior Medical Epidemiologist, Team Leader, WHE, COVID-19 IM, WHO-BAN, elsakkam@who.int
RCCE partners continue to conduct regular monitoring and rapid assessments to measure the effectiveness of the
interventions and to guide messaging as the outbreak and the response evolves.
7. Useful COVID-19 links:
WHO Bangladesh COVID-19 Situation Reports: https://www.who.int/bangladesh/emergencies/coronavirus-disease-
(covid-19)-update/coronavirus-disease-(covid-2019)-bangladesh-situation-reports
COVID-19 Situation in the WHO South-East Asia Region: https://www.who.int/southeastasia/outbreaks-and-
emergencies/novel-coronavirus-2019
Latest global WHO Situation Report # 154 as of 22 June 2020: https://www.who.int/emergencies/diseases/novel-
coronavirus-2019/situation-reports
WHO Bangladesh awareness and risk communication materials in Bengali:
https://www.who.int/bangladesh/emergencies/coronavirus-disease-(covid-19)-update
EPI-WIN: WHO information network for epidemics: https://www.who.int/teams/risk-communication
COVID-19 updates from the Directorate General of Health Services, Ministry of Health and Family Welfare, Government
of The People’s Republic of Bangladesh: https://dghs.gov.bd/index.php/en/home/5343-covid-19-update
Addressing violence against children, women and older people during the covid-19 pandemic: Key actions:
https://www.who.int/publications/i/item/WHO-2019-nCoV-Violence_actions-2020.1
Emergency Global Supply Chain System (COVID-19) catalogue: https://www.who.int/publications/i/item/emergency-
global-supply-chain-system-(covid-19)-catalogue
Feasibility, potential value and limitations of establishing a closely monitored challenge model of experimental COVID-
19 infection and illness in healthy young adult volunteers: https://www.who.int/publications/m/item/feasibility-potential-
value-and-limitations-of-establishing-a-closely-monitored-challenge-model-of-experimental-covid-19-infection-and-
illness-in-healthy-young-adult-volunteers
Institute of Epidemiology, Disease Control and Research (IEDCR): https://www.iedcr.gov.bd/
Recommended